Akouos, Inc. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2026-03-02: Study NCT07503613; Company role Lead sponsor; Phase Observational; Status Enrolling by invitation.
- 2025-01-17: Study NCT06517888; Company role Lead sponsor; Phase Phase 1, Phase 2; Status Recruiting.
- 2024-11-11: Study NCT06696456; Company role Lead sponsor; Phase Observational; Status Enrolling by invitation.
- 2023-09-15: Study NCT05821959; Company role Lead sponsor; Phase Phase 1, Phase 2; Status Recruiting.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2026-03-02 | NCT07503613 Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy | Lead sponsor | Observational | Enrolling by invitation | Vestibular Schwannoma | 100 | 2040-04 |
| 2025-01-17 | NCT06517888 Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma | Lead sponsor | Phase 1, Phase 2 | Recruiting | Vestibular Schwannoma | 27 | 2029-08 |
| 2024-11-11 | NCT06696456 Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy | Lead sponsor | Observational | Enrolling by invitation | Otoferlin Gene-mediated Hearing Loss | 30 | 2033-04 |
| 2023-09-15 | NCT05821959 Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss | Lead sponsor | Phase 1, Phase 2 | Recruiting | Sensorineural Hearing Loss, Bilateral | 22 | 2028-10 |
| 2022-07-14 | NCT05572073 Otoferlin Gene-mediated Hearing Loss Natural History Study | Lead sponsor | Observational | Recruiting | Sensorineural Hearing Loss, Bilateral | 150 | 2029-02 |